Life science & clinical diagnostics instruments > Metabolomics

High levels of beneficial fats found in breastmilk

09 October, 2023

Researchers have found that ether lipids are present in significantly higher concentrations in breastmilk compared to formula and other animal- and plant-based milks.

Metabolic markers predict how people will react to COVID

31 July, 2023

Researchers have revealed the key biological indicators that predict when a person will have a severe reaction to COVID-19.

New analytical technique uncovers >100 fatty acids

25 July, 2023

Researchers have uncovered 103 new unsaturated fatty acids in human-derived samples, doubling the number previously reported in human blood plasma.

Rapid cancer diagnosis using urine

07 April, 2023

Researchers have successfully developed a strip-type urine sensor that can amplify the light signal of metabolites in urine for diagnosing cancer in the field.

Microfluidic device enables less invasive cancer diagnostics

01 March, 2023

Researchers have developed a new device that can detect and analyse cancer cells from blood samples, enabling doctors to avoid invasive biopsy surgeries.

Metabolite delivery helps prevent food allergies

26 August, 2022

Scientists have designed a new way to deliver a bacterial compound known as butyrate, which has shown promise against allergic reactions in lab tests.

Asthmatics found to have a distinct metabolite profile

07 July, 2022

Severe asthmatics have a distinct biochemical (metabolite) profile detectable in their urine — a breakthrough that could lead to more effective treatments.

Embryo selection biomarkers help reduce time to pregnancy

22 December, 2021

Scientists have identified two biological markers to improve embryo selection for IVF patients, which should help them to get pregnant sooner.

Breath test helps tailor precise treatments for epilepsy

13 August, 2021

The new technology provides doctors with a non-invasive test that gives them immediate clues as to how well the course of therapy is going.

Biomarkers in urine can determine asthma subtypes

22 January, 2021

Researchers have used a urine test to identify and verify a patient's type of asthma, laying the foundation for a more personalised diagnosis and improved treatment.

Bruker B.I.QUANT-UR 1.1 module for metabolite quantification in urine

19 February, 2020

Bruker's B.I.QUANT-UR 1.1 module automatically quantifies up to 150 endogenous and disease-related metabolites from urine, allowing users to obtain precise, sensitive and fully reproducible results, even below the limit of detection (LOD).

Online metabolomics portal launches

04 October, 2018

PhenoMeNal is an online portal that allows researchers and clinicians to analyse large metabolomics datasets.

Metabolite measurement device inspired by Star Trek

26 September, 2018

A newly developed medical device pairs a handheld sensor with a smartphone app and measures the levels of various metabolites in fluid samples from patients.

Thermo Fisher and SRI partner to enhance small molecule research

11 July, 2017

Life sciences company Thermo Fisher Scientific and research centre SRI International have announced a collaboration to enhance small molecule research. 

Bruker B.I.QUANT-UR module of Avance IVDr NMR platform

27 June, 2017

Bruker has announced a product for the quantification of metabolites in urine using nuclear magnetic resonance (NMR). The B.I.QUANT-UR module of the company's Avance IVDr (In Vitro Diagnostics research) NMR platform is designed to provide precise, sensitive and fully reproducible results that have demonstrated potential in preclinical animal and clinical/translational research.

  • All content Copyright © 2023 Westwick-Farrow Pty Ltd